Marcell Dömötör, Judit Csősz, Lajos Kocsis, Iván Oroján
{"title":"[Argyria cutis following colloidal silver treatment in two patients with in situ melanoma].","authors":"Marcell Dömötör, Judit Csősz, Lajos Kocsis, Iván Oroján","doi":"10.1556/650.2025.33257","DOIUrl":null,"url":null,"abstract":"<p><p>Prior to the discovery and popularization of antibiotics, silver colloidal derivatives were widely used, mainly for the treatment of infections, due to their possible antibacterial and antiviral activity. The silver colloid solution contains microscopic silver particles suspended in a colloidal base. Although there are no clinical trials or reliable literature to prove its efficacy, the increasing interest in alternative and natural remedies has been accompanied by a parallel increase in the indication of silver colloid use for the treatment of various pathologies and for preventive purposes. In the following case reports, the authors detail the case of two male patients who developed in situ neoplastic skin lesions and consumed a daily silver colloid solution on the advice of a naturopath for malignancy prevention. The skin lesions showed no change but argyria has occurred in the skin and nailbed. The aim of this case report is to draw attention to the potential toxicity of silver colloid. The assessment of effectiveness of this therapy is not possible because the in situ neoplastic lesions (lentigo maligna melanoma and superficial spreading melanoma) without any treatment may stay in a preinvasive stage for decades. Orv Hetil. 2025; 166(13): 511–515.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"166 13","pages":"511-515"},"PeriodicalIF":0.8000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2025.33257","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Prior to the discovery and popularization of antibiotics, silver colloidal derivatives were widely used, mainly for the treatment of infections, due to their possible antibacterial and antiviral activity. The silver colloid solution contains microscopic silver particles suspended in a colloidal base. Although there are no clinical trials or reliable literature to prove its efficacy, the increasing interest in alternative and natural remedies has been accompanied by a parallel increase in the indication of silver colloid use for the treatment of various pathologies and for preventive purposes. In the following case reports, the authors detail the case of two male patients who developed in situ neoplastic skin lesions and consumed a daily silver colloid solution on the advice of a naturopath for malignancy prevention. The skin lesions showed no change but argyria has occurred in the skin and nailbed. The aim of this case report is to draw attention to the potential toxicity of silver colloid. The assessment of effectiveness of this therapy is not possible because the in situ neoplastic lesions (lentigo maligna melanoma and superficial spreading melanoma) without any treatment may stay in a preinvasive stage for decades. Orv Hetil. 2025; 166(13): 511–515.
期刊介绍:
The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history.
Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary.
The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.